Home/ Supplements/ Omega 3/ CO-Q-Omega

CO-Q-Omega

product on market Softgel Capsule Purity Products Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fatty acids and CoQ10 are supported by strong evidence for promoting cardiovascular health and cellular energy production. These ingredients help regulate lipid levels and support mitochondrial function. Current research indicates a high safety profile for these components when taken as directed.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CO-Q-Omega
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
30
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
5 mg (2% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
50 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)

Other Ingredients

highly refined and concentrated Omega-3 Fish Oil Capsule Shell Beeswax Coenzyme Q10 Proprietary LemonLock Freshness System
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, adults take 2 softgels daily. For daily use.

Warnings & Precautions

Contains fish (anchovy, sardines, mackerel) and soy.

Formulation Notes

Ultra-pure fish oil 640mg EPA 420mg DHA 50mg Coenzyme Q10

Promotes heart, joint & brain health Featuring LemonLock freshness system

Additional Information

Intelligent nutritional solutions

Premium grade supplements Since 1993

Metadata

Product Details

DSLD Entry Date2021-01-22
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID243505
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.